Michael Messinger
Direktor/Vorstandsmitglied bei FILAMENT HEALTH CORP.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Michael Messinger
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FILAMENT HEALTH CORP. | Direktor/Vorstandsmitglied | 28.03.2024 | - |
Karriereverlauf von Michael Messinger
Ehemalige bekannte Positionen von Michael Messinger
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CONTRAFECT CORPORATION | Comptroller/Controller/Auditor | 22.04.2014 | 04.12.2023 |
| Vorstandsvorsitzender | 15.11.2023 | 04.12.2023 | |
| Geschäftsführer | 15.11.2023 | 04.12.2023 | |
| Finanzdirektor/CFO | 01.11.2012 | 04.12.2023 | |
| Investor Relations Kontakt | - | 04.12.2023 | |
| Präsident | 15.11.2023 | 04.12.2023 | |
| Unternehmenssekretär | - | 04.12.2023 | |
| LEXICON PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.01.2001 | 01.01.2012 |
Coelacanth Corp.
 Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Coelacanth Corp. is a company that researches drug development. The company is based in East Windsor, NJ. The company was founded by Robert Grubbs. Coelacanth was acquired by Lexicon Pharmaceuticals, Inc. on 2001-07-12 for $31.9 million. | Comptroller/Controller/Auditor | 01.01.1999 | 01.01.2001 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01.01.1996 | 01.01.1999 |
Ausbildung von Michael Messinger
| University of Michigan | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Kanada | 2 |
Operativ
| Comptroller/Controller/Auditor | 3 |
| Director of Finance/CFO | 2 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 4 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| CONTRAFECT CORPORATION | Health Technology |
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| FILAMENT HEALTH CORP. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Coelacanth Corp.
Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Coelacanth Corp. is a company that researches drug development. The company is based in East Windsor, NJ. The company was founded by Robert Grubbs. Coelacanth was acquired by Lexicon Pharmaceuticals, Inc. on 2001-07-12 for $31.9 million. | Commercial Services |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
- Börse
- Insiders
- Michael Messinger
- Erfahrung
